Sharekhan is bullish on Coforge has recommended buy rating on the stock with a target price of Rs 4900 in its research report dated January 20, 2023.

Motilal Oswal recommended Neutral rating on Coforge with a target price of Rs 4040 in its research report dated January 21, 2023.

ICICI Direct is bullish on Coforge recommended buy rating on the stock with a target price of Rs 4870 in its research report dated January 20, 2023.

Coforge has signed the largest number of large deals in a quarter in its history. As a consequence, the order intake at $345 million has been the highest ever, said CEO Sudhir Singh

ICICI Direct is bullish on Coforge recommended buy rating on the stock with a target price of Rs 4570 in its research report dated October 21, 2022.

Sharekhan is bullish on Coforge has recommended buy rating on the stock with a target price of Rs 4680 in its research report dated October 20, 2022.

Emkay Global Financial recommended hold rating on Coforge with a target price of Rs 3550 in its research report dated October 21, 2022.

Healthcare Global Enterprises has broken out from the horizontal channel on the weekly charts. Price breakout is accompanied by jump in volumes. It is placed above all important moving averages, which indicates bullish trend on all time frames.

Given the expiry week, there could be volatility with also focus on global cues. If the index fails to sustain Friday's low of 17,710 then we can see further selling pressure, experts said.

Technical indicators are giving positive signals as Info Edge is trading above the 20 and 50 days SMA and there also recently a positive moving average crossover as the 20 days SMA moved above the 50 days SMA.